Burzynski Clinic

The Burzynski Clinic offers antineoplaston therapy—a peptide-based treatment developed by Dr. Stanislaw Burzynski—for various cancers. Despite decades of use and numerous early-phase studies conducted at the clinic itself, there are no robust randomized controlled trial data supporting efficacy or safety. The FDA has not approved any of its therapies for cancer treatment. Most positive results come from non-randomized case series authored by clinic staff; independent replication has failed. The approach remains highly controversial and widely criticized within mainstream oncology due to lack of scientific evidence and regulatory approval.